TARS Competitors & Alternatives
Compare Tarsus Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
TARS
Main Stock$68.20
Tradestie Score
61
Market Cap
$2.42B
Revenue Growth
0.7%
Analyst Upside
+46.3%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$80.39
|
$3.67B | - | 59 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$10.68
|
$3.59B | 15.6 | 38 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$19.73
|
$3.58B | 9.1 | 61 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$303.53
|
$3.49B | 32.4 | 50 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$9.15
|
$3.40B | 95.4 | 41 | Compare |
|
QURE
uniQure N.V.
|
$22.43
|
$3.39B | - | 63 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$41.49
|
$3.33B | - | 72 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$19.71
|
$3.31B | - | 46 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$20.55
|
$3.09B | - | 53 | Compare |
More TARS Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
217 stocks in this industry